NCT03847311 2025-01-09
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
University of Arizona
Phase 2 Completed
Clinical Trials
12 trialsNCT06557330 2025-01-06
MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma
Fox Chase Cancer Center
Phase 2 Not yet recruiting
NCT05580861 2024-05-29
SALMA
Assistance Publique - Hôpitaux de Paris
Phase 1/2 Recruiting
NCT05664464 2024-05-10
GLUGLIO
University of Zurich
Phase 1/2 Recruiting
NCT06134388 2023-11-18
Sulfasalazine in Patients With Metastatic Colorectal Cancer
Tanta University
Phase 3 Recruiting
NCT04205357 2023-03-03
SAS-GKRS
Haukeland University Hospital
Phase 1 Completed
NCT03449758 2022-04-28
SariPRO
Sanofi
Phase 4 Completed
NCT03734627 2021-08-16
EndoGut
St. James's Hospital, Ireland
Completed
NCT01198145 2020-05-12
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01577966 2016-12-08
Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma
University of Alabama at Birmingham
Phase NA Completed
NCT02456363 2015-05-28
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Chung Shan Medical University
Phase 2 Unknown
NCT02376478 2015-03-03
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection
Medical University of Vienna
Completed